R1 RCM Inc (RCM) Receives Consensus Recommendation of “Buy” from Brokerages

Shares of R1 RCM Inc (NASDAQ:RCM) have been assigned a consensus rating of “Buy” from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, three have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $11.75.

RCM has been the subject of a number of recent research reports. Cantor Fitzgerald boosted their target price on shares of R1 RCM from $10.00 to $11.00 and gave the stock an “overweight” rating in a report on Friday, August 10th. Zacks Investment Research downgraded shares of R1 RCM from a “hold” rating to a “sell” rating in a report on Tuesday, August 21st. BidaskClub upgraded shares of R1 RCM from a “hold” rating to a “buy” rating in a report on Thursday, August 30th. Chardan Capital initiated coverage on shares of R1 RCM in a report on Tuesday, September 4th. They issued a “buy” rating and a $17.00 target price for the company. Finally, TheStreet upgraded shares of R1 RCM from a “d+” rating to a “c” rating in a report on Tuesday, September 4th.

Shares of R1 RCM stock opened at $8.70 on Friday. The stock has a market capitalization of $983.31 million, a price-to-earnings ratio of -19.77 and a beta of -0.31. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 37.41. R1 RCM has a one year low of $3.90 and a one year high of $11.00.

R1 RCM (NASDAQ:RCM) last announced its earnings results on Wednesday, November 7th. The financial services provider reported ($0.17) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.12). The firm had revenue of $250.40 million during the quarter, compared to the consensus estimate of $240.09 million. R1 RCM had a negative return on equity of 132.32% and a negative net margin of 10.70%. The business’s revenue for the quarter was up 103.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.08) earnings per share. On average, sell-side analysts anticipate that R1 RCM will post -0.18 EPS for the current year.

In other news, Director Charles J. Ditkoff sold 20,635 shares of the company’s stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $8.47, for a total transaction of $174,778.45. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 59.40% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of RCM. Alps Advisors Inc. purchased a new stake in R1 RCM in the second quarter valued at approximately $655,000. Engineers Gate Manager LP purchased a new stake in R1 RCM in the second quarter valued at approximately $767,000. Rhumbline Advisers boosted its position in R1 RCM by 6.3% in the second quarter. Rhumbline Advisers now owns 97,414 shares of the financial services provider’s stock valued at $846,000 after buying an additional 5,770 shares during the last quarter. Teacher Retirement System of Texas purchased a new stake in R1 RCM in the second quarter valued at approximately $147,000. Finally, Bank of New York Mellon Corp boosted its position in R1 RCM by 20.4% in the second quarter. Bank of New York Mellon Corp now owns 390,447 shares of the financial services provider’s stock valued at $3,389,000 after buying an additional 66,099 shares during the last quarter. Hedge funds and other institutional investors own 57.42% of the company’s stock.

About R1 RCM

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

See Also: What are the components of an earnings report?

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply